Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients

被引:77
|
作者
Ng, Brendan J. [1 ,2 ,3 ,4 ]
Le Couteur, David G. [1 ,4 ]
Hilmer, Sarah N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Fac Med, Sydney, NSW, Australia
[2] Royal North Shore Hosp, Kolling Inst, Dept Aged Care, St Leonards, NSW, Australia
[3] Royal North Shore Hosp, Kolling Inst, Dept Clin Pharmacol, St Leonards, NSW, Australia
[4] Concord Hosp, Ageing & Alzheimers Inst, Concord, NSW, Australia
关键词
COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM USERS; AGED; 65; YEARS; INAPPROPRIATE BENZODIAZEPINE; GENERAL-PRACTICE; NURSING-HOMES; DOUBLE-BLIND; Z-DRUGS; HOSPITAL INPATIENTS;
D O I
10.1007/s40266-018-0544-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Benzodiazepines (BZDs; including the related Z-drugs) are frequently targets for deprescribing; long-term use in older people is harmful and often not beneficial. BZDs can result in significant harms, including falls, fractures, cognitive impairment, car crashes and a significant financial and legal burden to society. Deprescribing BZDs is problematic due to a complex interaction of drug, patient, physician and systematic barriers, including concern about a potentially distressing but rarely fatal withdrawal syndrome. Multiple studies have trialled interventions to deprescribe BZDs in older people and are discussed in this narrative review. Reported success rates of deprescribing BZD interventions range between 27 and 80%, and this variability can be attributed to heterogeneity of methodological approaches and limited generalisability to cognitively impaired patients. Interventions targeting the patient and/or carer include raising awareness (direct-to-consumer education, minimal interventions, and 'one-off' geriatrician counselling) and resourcing the patient (gradual dose reduction [GDR] with or without cognitive behavioural therapy, teaching relaxation techniques, and sleep hygiene). These are effective if the patient is motivated to cease and is not significantly cognitively impaired. Interventions targeted to physicians include prescribing interventions by audit, algorithm or medication review, and providing supervised GDR in combination with medication substitution. Pharmacists have less frequently been the targets for studies, but have key roles in several multifaceted interventions. Interventions are evaluated according to the Behaviour Change Wheel. Research supports trialling a stepwise approach in the cognitively intact older person, but having a low threshold to use less-consultative methods in patients with dementia. Several resources are available to support deprescribing of BZDs in clinical practice, including online protocols.
引用
收藏
页码:493 / 521
页数:29
相关论文
共 50 条
  • [21] Measurement and impact of comorbidity in older cancer patients
    Extermann, M
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 35 (03) : 181 - 200
  • [22] Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature
    Vartolomei, Liliana
    Shariat, Shahrokh F.
    Vartolomei, Mihai Dorin
    EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (04): : 283 - 291
  • [23] Feasibility of Perioperative eHealth Interventions for Older Surgical Patients: A Systematic Review
    Jonker, Leonie T.
    Haveman, Marjolein E.
    de Bock, Geertruida H.
    van Leeuwen, Barbara L.
    Lahr, Maarten M. H.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (12) : 1844 - +
  • [24] The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients-A Systematic Review
    Rasmussen, Anja Fog
    Poulsen, Sarah Sonne
    Oldenburg, Lykke Ida Kaas
    Vermehren, Charlotte
    METABOLITES, 2021, 11 (04)
  • [25] Impact of a deprescribing tool on the use of sedative hypnotics among older patients: study protocol for a cluster randomised controlled trial in Swiss primary care (the HYPE trial)
    Weiss, Katja
    Pichierri, Giuseppe
    Grischott, Thomas
    Groth, Susan
    Neuner-Jehle, Stefan
    BMJ OPEN, 2023, 13 (09):
  • [26] Frequency and Clinical Impact of Anticholinergic Burden in older patients: Comparing older patients with and without chronic kidney disease
    Yildiz, Serkan
    Heybeli, Cihan
    Soysal, Pinar
    Smith, Lee
    Veronese, Nicola
    Kazancioglu, Rumeyza
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2023, 112
  • [27] Impact of frailty in older patients with diabetes mellitus: An overview
    Cobo, Amelia
    Vazquez, Luis A.
    Reviriego, Jesus
    Rodriguez-Manas, Leocadio
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (06): : 291 - 303
  • [28] Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
    Cao, Bing
    Zhu, Judy
    Zuckerman, Hannah
    Rosenblat, Joshua D.
    Brietzke, Elisa
    Pan, Zihang
    Subramanieapillai, Mehala
    Park, Caroline
    Lee, Yena
    McIntyre, Roger S.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2019, 92 : 109 - 117
  • [29] Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson's Disease Patients
    Ciocca, Matteo
    Pizzamiglio, Chiara
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (05) : 554 - 561
  • [30] The impact of gratitude interventions on patients with cardiovascular disease: a systematic review
    Wang, Xiaoxiao
    Song, Chunli
    FRONTIERS IN PSYCHOLOGY, 2023, 14